Prevention, diagnosis, and treatment of obstructive sleep apnoea Meeting with Emilia-Romagna regional representatives about the OSAS Diagnostic-Therapeutic-Care Procedure (PDTA)
LIVE STREAMING EVENT
Chairperson: Luigi Ferini Strambi
Obstructive Sleep Apnoea Syndrome (OSAS) is the obstruction of the upper airways during sleep, characterised by repeated episodes of apnoea (in the most severe cases, dozens per hour of sleep). The syndrome is caused by an anatomical and/or functional change in the upper airways; adipose tissue deposits in overweight patients are one such cause. Apnoea triggers a sequence of damaging effects and is associated with various diseases. It is thought to reduce life expectancy, cause an estimated 7% of all traffic accidents, increase the risk of workplace injuries, and drive up healthcare costs both directly and indirectly. From a medical point of view, OSAS is a disorder requiring a multispecialty approach to guarantee optimal care for patients of all ages. Currently available treatment options include various medical devises, surgery, specialised diets, and innovative pharmacological regimens. OSAS is widely underdiagnosed. Beyond disseminating information about the risks correlated with the pathology, it is important to build a network of expertise to facilitate patient care and improve the quality of treatment.